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Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, New YorkABSTRACT A major current focus of structural work on G-protein-coupled receptors (GPCRs) pertains to the investigation of
their active states. However, for virtually all GPCRs, active agonist-bound intermediate states have been difﬁcult to characterize
experimentally owing to their higher conformational ﬂexibility, and thus intrinsic instability, as compared to inactive inverse
agonist-bound states. In this work, we explored possible activation pathways of the prototypic GPCR bovine rhodopsin by means
of biased molecular dynamics simulations. Speciﬁcally, we used an explicit atomistic representation of the receptor and its envi-
ronment, and sampled the conformational transition from the crystal structure of a photoactivated deprotonated state of
rhodopsin to the low pH crystal structure of opsin in the presence of 11-trans-retinal, using adiabatic biased molecular dynamics
simulations. We then reconstructed the system free-energy landscape along the predetermined transition trajectories using
a path collective variable approach based on metadynamics. Our results suggest that the two experimental endpoints of
rhodopsin/opsin are connected by at least two different pathways, and that the conformational transition is populated by at least
four metastable states of the receptor, characterized by a different amplitude of the outward movement of transmembrane helix 6.INTRODUCTIONG-protein-coupled receptors (GPCRs) are the largest family
of membrane proteins involved in communication between
the interior and exterior of cells, thus playing a central role
in pharmacology, neurobiology, and sensory physiology.
Rhodopsin—the protein that enables vision in low-light
conditions by converting photostimuli into biochemical
signals in the rod cell—represents a prototype for what is,
by far, the largest and most diverse family of GPCRs. Similar
to all the GPCRs, rhodopsin consists of seven transmem-
brane (TM) a-helices connected by alternating intracellular
(IC) and extracellular (EC) loops. Unlike other GPCRs,
however, rhodopsin is covalently bound to its natural ligand
11-cis-retinal via a protonated Schiff-base (SB) linkage to
a residue in the protein TM7 helix (i.e., residue K2967.43
in bovine rhodopsin, with the superscript referring to Balles-
teros and Weinstein’s generic numbering scheme (1)). The
11-cis isomer of the retinal chromophore acts as an inverse
agonist and stabilizes rhodopsin in its inactive (dark) state,
of which several crystal structures are available in the litera-
ture (recently reviewed in (2)). Absorption of a photon by
dark rhodopsin produces a fast isomerization of 11-cis-
retinal to 11-trans-retinal, which initiates a series of confor-
mational changes in the receptor leading to activation.
Despite the numerous studies on rhodopsin (3), the molec-
ular details of its activation mechanism are not fully under-
stood. The general view is that, after chromophore
isomerization, rhodopsin transforms itself into different pho-
tointermediate states with characteristic ultraviolet/visible
absorption spectra. Specifically, these photointermediateSubmitted September 4, 2009, and accepted for publication January 26,
2010.
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0006-3495/10/05/2347/9 $2.00states are: bathorhodopsin; a blue-shifted intermediate; lumi-
rhodopsin (LUMI); metarhodopsin I (MI); metarhodopsin II
(MII); metarhodopsin III (MIII); and ligand-free opsin, with
LUMI being the first intermediate state in which the retinal is
found in its 11-trans form. Two forms of inactive MI appear
to exist—MIa and MIb—with the latter capable of binding,
but not activating, the G-protein transducin (Gt) (4). The
active form of rhodopsin bound to 11-trans-retinal, i.e.,
MII, also exists in two forms in a pH-dependent equilib-
rium—MIIa and MIIb—with only the latter capable of acti-
vating Gt (5).
Two protonation-dependent switches occur during the
transition from the inactive MI to the active MII states (for
a recent review, see (6)):
1. Disruption of an inactivating salt bridge between the all-
trans-retinylidene SB and a complex counterion
composed of E1133.28 and E181 (EC2) by internal proton
transfer to the E1133.28 during the transition from MI to
MIIa; and
2. Proton uptake at E1343.49 in the E(D)RY motif, after
separation of the cytoplasmic ends of TM3 and TM6 rela-
tive to each other upon TM6 outward motion during the
transition from MIIa to MIIb (7), and leading to the
MIIbHþ state.
This movement is accompanied by the rupture of the salt
bridge, or ionic lock, between the charged side chains of
E2476.30 in TM6 and the E1343.49/R1353.50 pair in the
E(D)RY motif of rhodopsin. Breaking of this interaction
has repeatedly been shown to occur upon GPCR activation
(e.g., for a review see (8)). Phosphorylation of MII by
rhodopsin kinase and the subsequent binding to arrestin (9)
influence the formation of inactive products at the end of
the rhodopsin activation/inactivation cycle, such as MIII,doi: 10.1016/j.bpj.2010.01.047
2348 Provasi and Filizolawhich contains a protonated all-trans-retinylidene SB,
ligand-free opsin, and free all-trans-retinal.
Some of the early photointermediates of rhodopsin have
been thermally trapped in forms that could be characterized
structurally either by x-ray crystallography or electron cryo-
microscopy. Three-dimensional crystal structures of batho-
rhodopsin (10) and LUMI (11), together with a structural
model for MI based on cryo-electron microscopy of two-
dimensional crystals (12), demonstrate that the TM helix
bundle of rhodopsin does not undergo significant conforma-
tional changes during early photoactivation. No large struc-
tural rearrangements, but only alterations in portions of
IC2 and IC3 and in the density corresponding to the b-ionone
ring of 11-trans-retinal, were observed in the structural
model of a rhodopsin intermediate containing a deprotonated
SB based on low-resolution diffraction data from illuminated
rhodopsin crystals (13). However, the possibility cannot be
ruled out that the crystal lattice limits the magnitude of the
changes observed in this and other light-activated rhodopsin
structures (3). Notably, a recent high-resolution double elec-
tron-electron resonance (DEER) spectroscopy analysis of
distance changes between pairs of nitroxide side chains
introduced in helices at the cytoplasmic surface of rhodopsin
suggested a 5 A˚ outward movement of TM6 and smaller,
albeit significant, movements of TM1, TM7, and the
C-terminal portion after H8 upon activation (14).
In contrast to the early photoactivated states of rhodopsin,
no high-resolution crystal structures of either active MIIb or
the complex between MIIbHþ and Gt have been solved yet.
The recent crystal structures of ligand-free opsin at low pH
(15), or bound to a carboxy-terminal peptide of Gt (16),
are proposed to retain several characteristic features of an
active state. A dramatic rigid-body movement is observed
in these structures at the cytoplasmic end of TM6, which
appears to be shifted >6 A˚ outwards, and closer to TM5.
In this new conformation of TM6, the ionic lock is broken,
and new interactions are formed between R1353.50 and
Y2235.58, as well as between E2476.30 and K2315.66. This re-
arrangement of the ionic-lock residues is different from that
seen in the recent crystal structures of a photoactivated de-
protonated intermediate of rhodopsin (13), and in the
recently available non-rhodopsin crystal structures of b2-
adrenergic receptor, b1-adrenergic receptor, and adenosine
A2A receptor (see (17) for a review). Notably, the missing
ionic lock in the crystal structures of adrenergic and adeno-
sine receptors was restored during recent long molecular
dynamics (MD) simulations of these receptors in a lipid
bilayer under physiological conditions (18–21).
As important as the recent high-resolution x-ray crystal
structures of GPCRs have been for a structural understanding
of GPCR function, the spectrum of conformations that
a GPCR can assume depends upon the ligand to which it
binds and/or the proteins/lipids with which it interacts. It is
quite large, and thus calls for biophysical approaches thatBiophysical Journal 98(10) 2347–2355are capable of efficiently sampling the conformational space
of these inherently flexible systems. Several MD simulation
studies (nanosecond-to-microsecond range) have allowed
the description of the dynamic properties of inactive
rhodopsin and of some of its early photointermediates in
lipid bilayers and membrane mimetics (see (22) for a recent
review). Given the absence of experimental structural infor-
mation about the MII active form of rhodopsin and the
limited timescales accessible to standard MD compared to
the experimental timescale of MII formation (>1 ms (23)),
several investigators, including ourselves, have applied
various computational strategies. These strategies use exper-
imental known distance constraints to predict activated
models of GPCRs (see (22) for a recent review, and (24)
for the latest article).
In this work, we study the conformational transition from
the crystal structure of the photoactivated deprotonated inter-
mediate corresponding to the Protein DataBank (PDB) code
2I37 (13) to the low pH crystal structure of opsin (PDB
code: 3CAP) (15). This is performed in the presence of 11-
trans-retinal and an explicit hydrated 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) membrane bilayer,
using adiabatic biased MD (ABMD) simulations (25,26).
The assumption is that these two crystal structures are constit-
uent parts of the rhodopsin activation pathway. The thermo-
dynamic behavior of the system is then evaluated by
well-tempered metadynamics (27), an enhanced sampling
algorithm within the framework of classical MD that focuses
on adding a non-Markovian (history-dependent) bias to the
interaction potential in the space defined by a few collective
variables (CVs). Specifically, we used as reaction coordinates
both the position along and the distance from the preidentified
transition trajectories from ABMD, and carried out simula-
tions with either a charged or an uncharged residue E1343.49
within the E(D)RY motif. The results point to at least four
common metastable states of rhodopsin between the two
experimental endpoints used for simulation. Two of these
states may correspond to active conformations of rhodopsin,
as they are characterized by a significant separation of the cyto-
plasmic ends of TM3 and TM6 relative to each other, which is
known to be caused by TM6 outward motion during the tran-
sition from MIIa to MIIb (7). Based on these predicted confor-
mations, we tested the role of specific residues (e.g., K2315.66)
in locking rhodopsin in a certain state using metadynamics.MATERIALS AND METHODS
All calculations described in this section were performed using GROMACS
4.0.2 (28), enhanced with the PLUMED plug-in (29).
System setup and force ﬁeld
Rhodopsin molecular structure was obtained from the chain A of the pub-
lished crystal structure of a photoactivated deprotonated intermediate confor-
mation of the protein (PDB code: 2I37), and was described using the opti-
mized potentials for liquid simulations-all atom (OPLS-AA) force field.
The Free-Energy Landscape of Rhodopsin 2349Loop residues 230–238 and 311–313 that were missing from the crystal struc-
ture were built ab initio using the ROSETTA loop algorithm (30); the missing
C-terminal residues were not included in the simulations. Based on a validated
computational approach for the calculation of pKa values (31), the following
protonation states were assigned to histidine residues in the structure:
3-protonation to H651.60, H1524.41, H1955.30, and H2786.61, and d-proton-
ation to H1002.67 and H2115.46. Residues here and throughout the text are
numbered both according to their position in the bovine rhodopsin sequence
and to the Ballesteros-Weinstein generic numbering scheme (1) reported as
a superscript. In this two-number scheme, the first number (from 1 to 7) indi-
cates the helix the residue belongs to, while the second number represents the
residue position in that helix relative to its most conserved residue, which has
an assigned number of 50. To induce conformational transition to a fully
active state of the receptor, the SB was simulated in its deprotonated state,
whereas residues involved in the first of two protonation-dependent switches
(6), i.e., E1133.28, E1223.37, and D832.50, were protonated. To obtain a stable
11-trans form of the retinal throughout the simulations, the dihedral potential
of the chromophore’s C11-C12 bond was set to a minimum in its trans form.
Given the possibility for a proton uptake at E1343.49 from the intracellular
solvent (6), we have carried out either simulations with a negatively charged
or an uncharged E1343.49 residue. For the latter simulations, one Naþ ion was
removed to maintain the system neutral. Additional simulations were carried
out on mutant K2315.66A in the same conditions, neutralizing the system with
the appropriate number of Naþ ions.
To reduce the computational cost of an MD simulation of rhodopsin in an
explicit hydrated POPC membrane bilayer, a combined united-atom and all-
atom model by Tieleman et al. (32) was applied. Specifically, reparameterized
Berger united-atom lipid dihedral parameters (33) were used for the POPC
molecules in combination with the OPLS-AA parameters (34) for rhodopsin
and the ligand. A (75 75 91 A˚) pure POPC lipid patch was hydrated with
SPC/E water molecules and equilibrated for 50 nanoseconds (ns) by MD,
using this mixed force field. Bovine rhodopsin was inserted into this
membrane patch following the protocol described by Kandt et al. (35). Specif-
ically, the POPC bilayer and box size were inflated and, after insertion of
rhodopsin, compressed by a series of scaling steps alternating with energy
minimization. The process was terminated upon reaching convergence of
the surface area per lipid in the xy plane, and of the deuterium order parameter
profile to their published values (36), resulting in a 79  79  91 A˚ unit cell.
Two palmitoyl groups were covalently attached to the C-terminus residues of
the protein before insertion in the membrane. Finally, the system, consisting
of 345 amino acid residues of bovine rhodopsin, 130 POPC molecules, and
two palmitoyl groups, was hydrated with 9322 SPC/E water molecules
(37), with four Naþ ions added to ensure charge neutrality. Thus, the resulting
system of 45,322 total atoms was used as a starting conformation for MD
simulations in the NPT ensemble (constant pressure and temperature) under
periodic boundary conditions, using the Parrinello-Rahman algorithm (38).
This employed a barostat time constant of 1.0 picoseconds (ps) to maintain
a constant pressure of 1 bar, and the Nose´-Hoover algorithm (39) with
a time constant of 1.0 ps to maintain a constant temperature of 300 K. A series
of five 0.1-ns relaxation runs was first performed with increasingly weaker
positional restraints on the protein, followed by an unrestrained 2.0-ns equil-
ibration. During the subsequent simulation runs (see below), the dynamic
equations were integrated using a leap-frog algorithm (28) with a time step
of 0.002 ps. The LINCS algorithm (40) was used to preserve the bond lengths,
and the SETTLE algorithm (41) was used to maintain the geometry of the
water molecules. Lennard-Jones interactions were treated with a twin-range
cutoff of 0.9:1.4 nm and an integration time step of 2 fs; the neighbor list
was updated every 10 steps. Electrostatic interactions were described using
the particle-mesh Ewald method (42), with a cutoff of 0.9 nm for real-space
interactions, and a 0.12-nm grid with fourth-order B-spline interpolation for
reciprocal-space interactions.
Adiabatic biased MD runs
To describe the transition between the photoactivated deprotonated crystal
structure of rhodopsin bound to 11-trans-retinal (PDB: 2I37) and a confor-mation at the end of the rhodopsin activation/inactivation cycle, i.e., the low
pH opsin crystal structure (PDB: 3CAP), we applied an ABMD algorithm
(25,26). Like targeted molecular dynamics (TMD) (43), ABMD generates
transitions between conformational endpoints in single trajectories by
applying a constraint that reduces the root-mean-square deviation (RMSD)
between initial and target conformations. However, because in TMD the
minimization of the RMSD is always favored over the minimization of
the energy (i.e., RMSD from the target conformation is decreased by a preset
value at each MD step), this method does not necessarily follow the lowest
energy pathway (44). More efficient TMD-based algorithms for the simula-
tion of conformational transitions (e.g., the restricted perturbation TMD
method (44)) have been proposed in the literature. Among them is the
ABMD algorithm (25,26), which ensures exploration of low energy path-
ways by applying a time-dependent biasing potential, the unique feature
of which is to keep the total potential energy of the system continuous during
the MD run. Thus, following the main concepts described in the literature
(25,26), we defined the quantity c(R,t) as
cðR; tÞ ¼ dTM

RðtÞ;RðTÞmin
t
0
%t
dTM

R

t
0
;RðTÞ

; (1)
where R(t) is the conformation of the molecule at time t during the simula-
tion, R(T) is the target conformation, and dTM(R(t), R
(T)) indicates the mean-
square deviation (MSD) of the Ca atoms of the 163 TM residues between the
two structures. Thus, c is positive if the conformation R(t) is farther away
from the target than the closest structure sampled at time t. To drive the
system toward the opsin target conformation R(T), we applied the time-
dependent bias potential, as
UðR; tÞ ¼ kHðcðR; tÞÞcðR; tÞ2; (2)
where H is the Heaviside function, and k is an elastic constant. According to
Eq. 2, the bias acts only if c is positive, i.e., whenever the MSD of the TM
region of rhodopsin from the corresponding region in the opsin structure
exceeds the minimum value achieved during simulation. To identify the
smallest harmonic bias needed to carry out a reasonably slow path calcula-
tion, we carried out different ABMD simulations with different values of the
elastic constant. Specifically, we carried out four sets of 10 simulations using
different starting velocities and elastic constants (k ¼ 0.2, 0.02, 0.01, or
0.002 kJ/nm2 applied to 163 TM residues). A similar but independent
harmonic bias was also applied to the side-chain angle of W2656.48 to
promote the toggle switch expected upon activation. The first set of simula-
tions (k ¼ 0.2 kJ/nm2) reached the final state in ~0.5 ns, the second one
(k ¼ 0.02 kJ/nm2) in ~2 ns, and the third (k ¼ 0.01 kJ/nm2) in ~3 ns, while
the fourth set of simulations (k ¼ 0.002 kJ/nm2) did not move significantly
away from the starting conformation within a 10-ns time frame.
To obtain the least perturbed paths in a reasonable time frame, we carried
out 10 different 3 ns-long simulations with an elastic constant of
0.01 kJ/nm2, and independently drawn Maxwellian initial velocities, for
a total of 30 ns. Thus, all resulting trajectories were pooled, and the sampled
conformations grouped using average-linkage agglomerative hierarchical
clustering based on the RMSD of the TM domain. Grouping of all sampled
conformations ensured independence from a specific stochastic representa-
tion of the transition deriving from ABMD. Clustering was required to
define path collective variables for further metadynamics simulations (see
below). Thus, to select the maximum number of clusters k that would define
monodimensional paths, we calculated the permanence probability pk(i)
(i¼1,2,.,k) for each cluster, i.e., the probability by which the conformations
of a given trajectory remain in a specific cluster. We then calculated the over-
all product pk(1) pk(2). pk(k) of all clusters. A value of this product close to
1 means that switching between clusters is rare, and the clusters are visited in
a sequential fashion by the conformations of a given trajectory. If the number
of clusters k is large, the product decreases, indicating that the conformations
rapidly switch between at least two clusters. To avoid rapid switching
between clusters and to achieve a product closer to 1, we obtained
a maximum number of clusters k ¼ 4 (product ¼ 0.85).Biophysical Journal 98(10) 2347–2355
2350 Provasi and FilizolaFig. S1 of the Supporting Material shows the sequence of clusters visited
by the receptor along the 10 different ABMD trajectories. As shown in this
figure, these 10 trajectories can be classified into two groups of qualitatively
different conformational transitions (A and B in Fig. S1), which all end in
cluster 3 (orange and dark green in trajectories of transitions A and B,
respectively). All structures sampled in these trajectories were then analyzed
by embedding them in a two-dimensional Euclidean metric space using clas-
sical linear multidimensional scaling (45). Briefly, classical multidimen-
sional scaling consists of a dimensional reduction algorithm that allows
mapping the complex multidimensional data (coordinates of the structures)
on a low-dimensional manifold (e.g., bidimensional points whose distance
provides a rough estimate of the MSD between the structures). More details
about this algorithm are provided in the Supporting Material.
Metadynamics simulations
To obtain information about the relative stability of the states populated by
rhodopsin during transition from its photoactivated deprotonated crystal
structure to the target opsin conformation, we performed metadynamics
simulations, using as CVs the position (s) along, and the distance (z)
from, the ABMD-predetermined trajectories. For each of the two differ-
ent conformational transitions that derived from the ABMD simulations
(A and B in Fig. S1), we defined path collective variables using the sequence
of the most populated clusters for either transition A (three clusters) or B
(four clusters). To achieve smoother descriptions of the conformational tran-
sitions, we linearly interpolated the structures, and obtained k ¼ 10
uniformly spaced reference conformations R(i) with 1 % i % k. These
reference frames, k, were used to define as CV the position of the protein
(0% s% 1) along the predetermined transition trajectory, according to Eq. 3,
sðRðtÞÞ ¼ Z1
Xk
i¼ 1
i 1
k  1e
ldTM

RðtÞ;RðiÞ

; (3)
where the constant exponent l was chosen in such a way that l  d y 1,
having called d ¼ hdTM(R(i),R(i51))i the average distance between two adja-
cent frames in the transition discretization. Z is a normalization factor
defined by Eq. 4:
Z
Xk
i¼ 1
eldTM

RðtÞ;RðiÞ

: (4)
The same framework also allowed us to define a CV (see Eq. 5, below) that
describes the distance of the protein conformation from the ABMD predeter-
mined conformational transitions. Such an additional dimension is crucial to
allow the global description of transitions different from the one used to
define the reference path (46,47):
zðRðtÞÞ ¼ l1 log Z: (5)
The well-tempered metadynamics algorithm (27) in its direct formulation
was used to reconstruct the free-energy of rhodopsin as a function of the
two variables defined in Eqs. 3 and 5. Specifically, an initial Gaussian height
W0 ¼ 0.1 kcal/mol and a deposition rate t0 ¼ 1 ps were chosen. According to
the well-tempered metadynamics prescription, the bias was updated by add-
ing Gaussian contributions with a total height of
W ¼ W0 exp

 Vtðs; zÞ
fT

; (6)
where T is the simulation temperature, Vt(s,z) is the bias potential at time t for
the values s and z of the CVs, and the bias factor f was chosen to be 15 to
allow the system to overcome barriers of the order of 15 kT ~ 9 kcal/mol.
To have a qualitative idea of the error associated with these calculations,
we carried out the well-tempered metadynamics simulation three times,
starting from different initial conformations extracted from the ABMD
runs. The simulation length was 80 ns for each of the different metadynamicsBiophysical Journal 98(10) 2347–2355runs carried out in this study for both wild-type and mutant rhodopsin
(K2315.66A) with either a charged or an uncharged residue E1343.49 within
the E(D)RY motif. To restrain the sampling to the region of interest, the
value of the variable z was calculated for all the states along the trajectories
generated using ABMD, and a steep repulsive wall was placed at its
maximum value zMax ¼ 0.1 A˚2 during the metadynamics simulations. To
enable a more direct comparison between the free-energy landscapes recon-
structed for the two different reference transition trajectories (A and B in
Fig. S1) identified in this study, a common value of l ¼ 0.1 nm2 was
chosen. Convergence of the reconstructed free-energy was monitored by in-
specting the free-energy profile, and plotting as a function of the time the
predicted free-energy difference between the minima revolving around the
experimental endpoints. Fig. S2 and Fig. S4 report these differences for
each of the simulations (charged or uncharged E1343.49) carried out for
wild-type or mutant rhodopsin, respectively. As shown in these figures,
free-energy estimates converge to similar values (within 0.3 kcal/mol)
during the last 20 ns of simulation. An additional support for simulation
convergence comes from the observed frequent recrossing of the values of
the collective variables during time, as shown in Fig. S4.RESULTS AND DISCUSSION
In this article, we describe the results of a new computational
strategy that combines ABMD simulations with metadynam-
ics analysis to explore the thermodynamics of late activation
events of bovine rhodopsin.
Membrane environment
To accurately model conformational transitions in GPCRs,
a complete explicit description of their environment is in
order. In fact, the viscoelastic properties of the membrane
can strongly influence the photoactivation cycle of rhodopsin
(48). Specifically, lipids with polyunsaturated chains can
destabilize the native state of rhodopsin, whereas rhodopsin
reconstituted in fully saturated lipids exhibits impaired acti-
vation. Similarly, cholesterol molecules can stabilize the
receptor, thus slowing its kinetics (e.g., see (49)).
Recent computational studies have confirmed the role of
the membrane scaffold on the dynamic properties of
rhodopsin (e.g., see (50)). In the simulations described here-
after, we considered a representation of the rhodopsin solva-
tion system including a hydrated unsaturated POPC
membrane bilayer, and two palmitoyl groups bound to the
protein C-terminus. The latter were considered in the
rhodopsin modeling and simulations because these groups
are found to be bound to rhodopsin under physiological
conditions, as a result of posttranslational fatty acid acylation
of two cysteines at the cytoplasmic end of the receptor.
Transition from photoactivated deprotonated
to opsinlike states
Ten statistically independent 3-ns-long ABMD simulations
were performed between the photoactivated deprotonated
crystal structure of rhodopsin (PDB: 2I37) and the low pH
crystal structure of opsin (PDB: 3CAP) in the presence of
11-trans-retinal, and of an explicit hydrated POPC lipid
bilayer. To capture the essence of the conformations
The Free-Energy Landscape of Rhodopsin 2351sampled, we performed a cluster analysis and described each
trajectory using the temporal sequence of cluster occupancy
(see Materials and Methods for details). Inspection of the
timelines reported in Fig. S1 shows that trajectories 1–7
(brown-to-yellow color in Fig. S1) share a common pattern
of occupancy, going through the same clusters in the same
temporal sequence (clusters 1-2-3) with only sporadic visits
to cluster 4 from cluster 2. The same is true for the remaining
three simulations (trajectories 8–10; clusters 1-2-4-3), also
reported in Fig. S1 (purple-to-green color). Thus, the 10
trajectories could be divided into two groups, termed here
A (transition described by the first seven trajectories) and B
(transition described by the last three trajectories).
We then elucidated the topology of the conformational
space sampled by ABMD by embedding the multidimen-
sional structures resulting from representative trajectories
of transitions A and B (i.e., trajectories #1 and #8 in
Fig. S1, respectively) in a low dimensional Euclidean space
using multidimensional scaling. The resulting plot (reported
in Fig. 1) shows a dot (brown-to-yellow for A and purple-to-
green for B) for each of the sampled conformations along the
two representative trajectories. Coordinates of these confor-
mations have been mapped on a two-dimensional plane in
such a way that distances among the different dots provide
a rough estimate of the MSD among different TM domains.
As shown in Fig. 1, these conformations form four definite
clusters (clusters 1–4) for both transitions A and B. To relate
the sampled conformations to the experimental endpoints
used in the simulations, the crystal structures of bovine
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FIGURE 1 Multidimensional embedding of two ABMD trajectories,
representative of transitions A and B, progressing chiefly through four clus-
ters (brown-to-yellow and purple-to-light green, respectively). Of note, clus-
ters C1–C4 are obtained from the pooled trajectories of 10 ABMD
simulations. (Black dots) Points corresponding to the cluster centroids and
to the experimental structures of 2I37 and 3CAP.rhodopsin/opsin corresponding to PDB codes 2I37 and
3CAP were also embedded in the same fashion, and their
position with respect to the conformations sampled is indi-
cated with arrows and black dots in Fig. 1. As expected,
the opsin target structure 3CAP falls close to the cluster at
the end of the ABMD runs, while the starting photoactivated
deprotonated crystal structure 2I37 is very close to the first
cluster of sampled conformations.Metastable states along possible activation
pathways
As described in Materials and Methods, ABMD representa-
tive trajectories of transitions A and B were used to define the
reaction coordinates for metadynamics runs to explore the
thermodynamics of the late events of rhodopsin activation.
The RMSD of the TM region of the receptor with respect
to selected conformations (centers of clusters in Fig. 1) along
the representative trajectory of transition A was used to
derive two collective variables (see details in Materials and
Methods) that described the progression (s) of the system
from the experimental photoactivated deprotonated confor-
mation of rhodopsin to the opsin state, and its distance (z)
from it. These two collective variables were used to run
metadynamics simulations on wild-type rhodopsin/opsin
with either a charged or an uncharged residue E1343.49
within the E(D)RY motif, and to reconstruct the free-energy
of the system as it moved along the different states.
The reconstructed free-energy surfaces of transition A
after 80-ns simulations (see Fig. 2, A and B, for average
free-energy surfaces based on three different simulations of
wild-type rhodopsin with a charged or uncharged E1343.49,
respectively) confirm that the proposed late activation
pathway of rhodopsin involves at least four states, including
a photoactivated deprotonated conformation similar to 2I37
(state 1), and an opsinlike conformation similar to 3CAP
(state 3). Integration of these average free-energy surfaces
yielded the monodimensional plots of Fig. S5, A–C, where
the blue lines refer to the three simulations with charged
E1343.49, and the red lines are representative of the three
simulations with uncharged E1343.49. As seen in Fig. S5 C
showing a comparison between average values of these
simulations, state 1 (2I37-like) has a slightly higher free-
energy in the simulations with uncharged E1343.49, whereas,
in the same simulations, state 3 acquires a free-energy similar
to the combined states 2/4. In contrast, the simulations with
charged E1343.49 show a less stable state 3 compared to
combined states 2/4 and state 1.
For a structural characterization of these states, we
compared structural differences at specific positions between
each state and the inactive rhodopsin structure corresponding
to PDB code 1GZM. Similar to experimentally measured
distance changes (performed by DEER spectroscopy (14))
that occurred upon activation (see column 8 of Table S1,
where negative values indicate inward movements, andBiophysical Journal 98(10) 2347–2355
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FIGURE 2 Average two-dimensional energy surfaces of
wild-type rhodopsin with (A) a charged or (B) an uncharged
residue E1343.49 as a function of the two path collective
variables s and z that describe the progression along the
transition trajectory A obtained by ABMD. Contour interval
is 1 kcal/mol. Averages are based on sets of three different
simulations starting from different conformations.
2352 Provasi and Filizolapositive values suggest outward movements), we measured
distance changes at specific positions between 1GZM and
any of the following structures: 2I37, state 1, state 2, state
3, state 4, or 3CAP (reported in columns 2, 3, 4, 5, 6, and
7 of Table S1, respectively). Specifically, these distances
were measured between selected rhodopsin residues (re-
ported in column 1) and the center of the receptor (defined
as the point halfway between the location of residues 74
and 252 in the inactive state of rhodopsin). Nevertheless,
these calculated values should be considered with caution
as they refer to biased estimates, and are therefore not
weighted with a proper Boltzmann’s factor.
State 1, located around sz 0.2 and 0% z% 0.01 A˚2 in
Fig. 2 A, and very close to the starting photoactivated depro-
tonated conformation, was found to lie in a local free-energy
minimum separated by a barrier of 1.8 kcal/mol from the
adjacent metastable state (state 2 in Fig. 2 A). The conforma-
tions that populate this basin, once extracted and visually in-
spected, are found to be structurally homogeneous and to
form a compact cluster. Not surprisingly, these conforma-
tions are similar to the representative conformations of C1
(see Fig. 1), used to define the collective variables. The
two key residues R1353.50 and E2476.30 are sufficiently close
to have the ability to form the distinctive ionic lock, which is
a characteristic feature of inactive structures of GPCRs (see
Fig. 3 A). A comparison of columns 2 (distance changes in
2I37) and 3 (distance changes in state 1) of Table S1
confirms the structural similarity between our identified state
1 and the 2I37 crystal structure.
In addition to state 1, the simulation identified two other
metastable states at small values of z, termed state 2 and state
3 in Fig. 2 A. State 2 (0.4% s% 0.8 and zz 0 A˚2 in Fig. 2
A) features a large displacement of the TM helices, especially
TM6, which moves outward ~4 A˚ (see Table S1, column 5)
upon the release of the lock between R1353.50 and E2476.30
(Fig. 3 B). The W2656.48 toggle switch is also observed in
this state. State 3 (s z 0.9 and 0 % z % 0.01 A˚2 in Fig. 2
A), resembles the opsin conformation. The sixth column of
Table S1 reports the values of the aforementioned distanceBiophysical Journal 98(10) 2347–2355variations calculated for this state with respect to the
1GZM conformation. As in the opsin conformation, whose
distance changes are reported in column 7 of the table, state
3 shows a sensible inward movement of helix TM5
(1.9 A˚), and much more pronounced outward movements
of TM6 (4.9 A˚) and IC3 (5.6 A˚) with respect to state 2.
A superposition between state 3 of the receptor and its initial
2I37 conformation (see Fig. 3 C) shows that TM3 does not
change its position in the bundle, but rather TM6 moves
outwards. Owing to the large change in the TM3/TM6 rela-
tive position, the ionic lock between the two charged resi-
dues R1353.50 and E2476.30 in rhodopsin state 3 is broken,
with the glutamic acid now participating in a robust
hydrogen-bonded network involving residues T2516.34 and
K2315.66 (see Fig. 3 C, inset), which appears to stabilize
the interaction between helices TM5 and TM6 in this meta-
stable state. Unlike the opsin structure, state 3, which has an
11-trans retinal bound to it, exhibits the W2656.48 toggle
switch attributed to an active structure. In light of recent
solid-state nuclear magnetic resonance measurements sug-
gesting a displacement of the EC2 loop from the retinal
binding site upon activation (51), we analyzed the conforma-
tion that this loop acquired in the proposed active states 2 and
3. In state 2 (less pronounced outward movement of TM6),
EC2 did not undergo a significant conformational change
with respect to a rhodopsin inactive structure. On the other
hand, in state 3 (more pronounced outward movement of
TM6), the loop exhibited distances from both the protein
and the chromophore that were in line with the reported
nuclear magnetic resonance data. For instance, the distance
between the Ca atom of the EC2 G188 residue and the
C19 carbon of the retinal polyene chain increased to 6.0 A˚
from a 4.8 A˚ distance measured between the same atoms
in the inactive rhodopsin structure 1GZM. Also in agreement
with experimental data, preexisting contacts between S186
in EC2, and the C12 and C20 atoms in the retinal, as well
as between the EC2 residue G188 and the TM residue
Y2686.51, are broken in state 3 (but not in state 2), suggesting
that the shift of the retinal and the rearrangement of the loop
B  Cluster 2
TM3
E1343.49
TM5
TM6
E2476.30
R1353.50
Y1363.51
E1343.49
R1353.50
Y1363.51
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C Cluster 3
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K2315.66
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D  Cluster 4
FIGURE 3 Structural features of representative confor-
mations of wild-type rhodopsin extracted from the low
free-energy basins illustrated in Fig. 2 A. The structures
are compared with the 2I37 structure (in cyan). Helices
TM3, TM5, and TM6 (in red, green, and blue, respectively)
are highlighted, and residues discussed in Results and
Discussion are depicted as black sticks.
The Free-Energy Landscape of Rhodopsin 2353occurs simultaneously to the larger outward movement of
TM6 in this state. However, at variance with the experi-
mental data, the distance between the EC2 residue Y178
and the TM residue G1143.29 did not increase beyond
5.5 A˚ in state 3.
Although completely different pathways may still exist,
the proposed combined ABMD-metadynamics approach
provides an efficient exploration of the conformational space
of rhodopsin through its use of collective variables (e.g., z)
that allow deviations from predetermined transition paths.
For instance, exploration of the reconstructed free-energy
surface of transition A (Fig. 2 A) at larger values of z identi-
fied a well-defined and localized state 4 (sz 0.8 and 0.02%
z% 0.03 A˚2), far from the conformations of the representa-
tive trajectory of transition A that were used to define the
collective variables for metadynamics. State 4 is character-
ized by slight distance changes (<2.5 A˚ in column 4 of Table
S1), which are nevertheless sufficient to break the ionic lock
at the cytoplasmic side (Fig. 3 D). Visual inspection of the
conformations in the free-energy basin 4 confirms their simi-
larity to the structures visited in C4 of the ABMD runs 8–10
that define transition B (see Fig. 1). To further show the simi-
larity between these structures, we performed a second set of
metadynamics simulations on the B transition (Fig. S1),
using path collective variables derived from the alternative
representative trajectory from ABMD. The reconstructed
average free-energy of transition B is reported as a functionof these variables in Fig. S6. Conformations extracted from
the basins identified by these metadynamics simulations
were indeed similar to those characterized by the first set
of metadynamics runs using frames from transition A.Mutations stabilizing different amplitudes of TM6
opening
The aforementioned results provide insights into the interac-
tions that stabilize the metastable intermediates sampled by
rhodopsin during late activation events. Thus, specific
mutants might be designed that feature engineered stabilities
with respect to wild-type rhodopsin. Given the importance of
accurate structural information on intermediate states, we
searched for mutations that would lock the receptor in
specific conformations, possibly facilitating their experi-
mental characterization.
A contact map difference between conformations ex-
tracted from states 2 and 3, pointed to K2315.66 as the residue
whose contacts differed the most between the two proposed
active states of rhodopsin exhibiting a significant separation
of TM6 apart from TM3. We could not find in the literature
any experimental information on mutations at this position.
Notably, the recent opsin crystal structures drew attention
to the K2315.66 residue as it participated in a new interaction
with E2476.30. This interaction was maintained in all confor-
mations extracted from the energy basin of state 3.Biophysical Journal 98(10) 2347–2355
2354 Provasi and FilizolaTo test the importance of this interaction in stabilizing an
opsinlike conformation, we repeated the metadynamics
simulations described for wild-type rhodopsin using a model
of a mutant receptor, in which the key residue K2315.66 was
mutated to alanine, thus neutralizing the interaction between
the cytoplasmic ends of helices TM5 and TM6 in their outer-
most conformation, achieved in basin 3. The rationale behind
this proposed mutation is that an enthalpic destabilization of
state 3 would lead to a larger fraction of receptors being
locked in the previous state 2, thus increasing the chances
for us to obtain relevant experimental information on this
state. The resulting average free-energy, reconstructed from
three different metadynamics simulations as a function of
the variables s and z defined above, is depicted in Fig. S7.
Although the overall topology of the free-energy surface is
very similar to that of wild-type rhodopsin (Fig. 2), the pre-
dicted destabilization of state 3 in the mutant simulations is
particularly evident from the data reported in Fig. S5, D–F,
where the blue lines refer to the simulations of the
K2315.66A mutant with charged E1343.49 and the red lines
are representative of the K2315.66A mutant simulations
with uncharged E1343.49.CONCLUSIONS
To the best of our knowledge, this is the first time that possible
activation pathways and metastable active states of GPCRs are
proposed as the result of free-energy calculations from biased
MD simulations toward an opsinlike conformation. The
results of ABMD simulations on bovine rhodopsin point to
at least two different transitions between an experimental pho-
toactivated deprotonated state of the receptor and an opsinlike
state in the presence of 11-trans-retinal. The thermodynamic
behavior of the system along these proposed activation path-
ways was evaluated by several different metadynamics runs,
using as reaction coordinates both the position along, and
the distance from, preidentified representative transition
trajectories obtained by ABMD. At least four common meta-
stable states were confirmed between the crystallographic
structures 2I37 and 3CAP. Based on intramolecular distance
analysis and comparison to experimental values obtained by
DEER spectroscopy, we propose that two of these metastable
states are putative active states along the pathway describing
late activation events of rhodopsin. Structural analysis of the
two minima exhibiting significant outward movement of
TM6 (states 2 and 3) suggested a specific residue (K2315.66)
whose mutation would contribute more significantly to the
stabilization of one state over the other. In fact, additional
metadynamics simulations carried out on the K2315.66A
mutant revealed a less stable state 3 for this system, which
appeared to be trapped into a more stable state 2. Based on
inferences from these simulations, we propose this mutant as
worth of experimental testing, as its experimental characteriza-
tion may shed new light into mechanisms of allosteric modu-
lation of rhodopsin function.Biophysical Journal 98(10) 2347–2355SUPPORTING MATERIAL
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